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Abstract: 
Computational and mathematical modelling has become a valuable tool for investigating 
biological systems. Modelling enables prediction of how biological components interact to 
deliver system-level properties, and extrapolation of biological system performance to 
contexts and experimental conditions where this is unknown. A model’s value hinges on 
knowing that it faithfully represents the biology under the contexts of use, or clearly 
ascertaining otherwise and thus motivating further model refinement. These qualities are 
evaluated through calibration, typically formulated as identifying model parameter values 
that align model and biological behaviours as measured through a metric applied to both. 
Calibration is critical to modelling, but is often under-appreciated. A failure to appropriately 
calibrate risks unrepresentative models that generate erroneous insights. Here we review a 
suite of strategies to more rigorously challenge a model’s representation of a biological 
system. All are motivated by features of biological systems, and illustrative examples are 
drawn from the modelling literature. We examine the calibration of a model against 
distributions of biological behaviours or outcomes, not only average values. We argue for 
calibration even where model parameter values are experimentally ascertained. We explore 
how single metrics can be non-distinguishing for complex systems, with multiple component 
dynamic and interaction configurations giving rise to the same metric output. Under these 
conditions, calibration is insufficiently constraining and the model non-identifiable: multiple 
solutions to the calibration problem exist. We draw an analogy to curve fitting and argue 
that calibrating a biological model against a single experiment or context is akin to curve 
fitting against a single data point. Though useful for communicating model results, we 
explore how metrics that quantify heavily emergent properties may not be suitable for use 
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in calibration. Lastly, we consider the role of sensitivity and uncertainty analysis in 
calibration and the interpretation of model results. Our goal in this manuscript is to 
encourage deeper a consideration of calibration, and how to increase its capacity to either 
deliver faithful models or demonstrate them otherwise. 
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Main Body 
 
Introduction 
 
Explored in ever greater depth, our appreciation of the sheer inherent complexity of 
biological systems grows [1]. Important system-level properties, such as disease and health, 
emerge from local interactions amongst vast numbers of molecular and cellular components 
[2]. These emergent properties cannot be predicted from examination of system 
components in isolation [3,4]. As immunologist Irun Cohen reflects: “The more data we have 
access to, the more confused we have become” [5]. Consequentially, computational and 
mathematical modelling has arisen as a “constructionist” tool that complements 
reductionist techniques [6]. Models reveal how local-level component dynamics impact 
system-level performance, and can predict real system behaviour in a given context. That 
anything can be manipulated or measured in a model is arguably its greatest upside [7,8]. 
The greatest downside is the risk that a model is unrepresentative of the biology, and hence 
misleads rather than informs.  
 
Two aspects of biological modelling can give rise to unrepresentative models, and 
complicate the interpretation of modelling results. First, models are abstract 
representations of the systems they seek to capture. Despite advances in multi-scale 
modelling [9,10], it is currently both technologically and conceptually impossible to fully 
model a biological system, from the molecule, through the cell and then organism, to the 
ecosystem. Low-level process dynamics are abstracted and summarily represented, e.g. as 
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distributions. Many biological components are similarly omitted, amalgamated or 
abstracted, and together they are represented in a simplified subset of the full spatial 
environmental. It is rarely known a priori what the most appropriate abstractions of a 
biological system will be [11]. Some mathematical models can capture realistic population 
sizes of system components. For others, such as agent-based modelling wherein every 
individual component of the model is explicitly represented [12], this is impractical. Second, 
the biological system is likely incompletely understood; gaining a greater understanding may 
in fact motivate the modelling enterprise. How, then, does one construct a representative 
model of such a system? The implication is that we cannot assume a direct mapping of 
biological- to model-component(s), neither in terms of component concept, dynamics nor 
population size. Rather, establishing and testing this mapping is accomplished through 
model calibration [7]. 
 
We distinguish between model mechanics and parameters. A model’s components, and the 
dynamics they are capable of, represent its mechanics. A model’s parameters assign rates 
and probabilities to component dynamics, and values to initial conditions. At the very least, 
calibration must seek to establish suitable parameter values. Ideally, however, calibration 
should be capable of detecting inappropriate model mechanics, and thus unrepresentative 
models. 
 
Calibration approaches typically seek parameter values that align model and real-world 
behaviours and outcomes under some single context or experimental condition. Approaches 
range from manual exploration of putative parameter values, drawing heavily on domain 
expertise [13,14], to automation. Domain experts can help overcome a lack of available 
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data, or conflicts and inconsistencies therein [15], but can prove inferior to systematic 
approaches [14,16]. Automated calibration approaches include the use of heuristic search 
algorithms [17,18], Bayesian methods such as Markov chain Monte Carlo and maximum 
likelihood [4,19], Kalman filters [20], and standard curve fitting techniques [21,22].  
 
Here we explore strategies aimed at increasing the power of calibration to either deliver 
representative, accurate models, or demonstrate them otherwise. Our aim is not to review 
the specific fitting technologies cited above, but to explore the broader contexts through 
which calibration can be performed.  
 
 
Diverse sources for model parameter values and mechanics 
 
Modellers can industriously delve through literature seeking experimental sources for 
model parameter values. For instance, Efroni et al. report sourcing parameter values from 
around 300 papers in their modelling of thymic T cell maturation [23]. We posit that, even 
where putative values for all model parameters can be extracted from the literature, 
adjustment and tuning through calibration is still warranted. In reproducing biological 
system dynamics, components included within a model must compensate for the activities 
of those that are omitted or abstracted. For instance, as key mediators of the adaptive 
immune response, T cells feature heavily in immunological models [24,25]. Currently, 29 
distinct subsets of T cell are recognised [26], encompassing a functional richness and nuance 
beyond most models’ aspirations. A modelled “T cell” may not correspond exactly with any 
single subset, but rather an integration of several. Hence, putative model parameters 
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originating from measurements of a specific subset may still warrant adjustment to account 
for abstraction. This principle is further compounded if data derives from different 
experimental systems, be they different organisms or systems of study, e.g. humans, mice 
or zebra fish, in vivo, in vitro or other in silico models. For instance, in vivo, ex vivo and in 
vitro studies have found differing effects of stress on NK cell cytotoxicity [27]. Elsewhere, 
differing transcriptomics results between in vitro and in vivo toxicology studies pose a 
challenge for the pharmaceutical industry [28]. Lastly, cell migration patterns can differ 
substantially between in vivo and in vitro contexts [29]. 
 
Responses to intervention can also differ considerably across organisms, reflecting 
mechanistic differences in biological components. For instance, in a study of over 100 
strains of mouse commonly used in research, the development of insulin resistance, and 
associated metabolism and physiology, in response to high fat-high sucrose diets was found 
to vary by over an order of magnitude [30]. Further, the effect of caloric restriction on 
lifespan, body weight, core body temperature, insulin sensitivity, metabolism, and 
pathology has been found to differ between mouse strains and sexes [31,32]. 
 
When acquired from multiple experimental systems, particularly those other than the 
specific system being modelled, putative parameter values are better thought of as 
guidelines than prescriptions. Yet calibration is not always reported in modelling literature, 
even when estimates for particular parameters vary by several orders of magnitude, e.g. 
Swerdlin et al. cite literature reporting the frequency of B cells specific for a given antigen to 
lie in the range of 1 in 10k to 1 in 1,000K [33].  
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An alternative to obtaining parameter values from highly diverse sources is to extensively 
interrogate the exact experimental system being modelled, and calibrate parameters 
against these data. For instance, in modelling hematopoietic stem cell expansion dynamics 
under given cytokine exposure, Gullo et al. acquired extensive experimental data of 
expansion from the exact in vitro system they were modelling for use in calibration [34]. To 
calibrate their model of the immune response in murine tuberculosis, Marino et al. 
quantified four key leukocyte population sizes in the lymph nodes and lungs at 7 time points 
post-infection obtained from 80 mice [35]. From 5000 samples of model parameter value 
space, the single set of values most closely (qualitatively) resembling in vivo dynamics was 
selected as the starting point for calibration. 130 parameters, those related to leukocyte 
dynamics, were calibrated; the remaining 80 retained these starting values. This practice 
can mitigate the diversity of experimental systems from whence parameter values are 
drawn as a source of uncertainty or error, though ideally sufficient data is extracted to 
calibrate all model parameters. Putative parameter values sourced from elsewhere can 
form initial values or boundaries of exploration for calibration.   
 
 
Calibrating to reproduce distributions of outcomes 
 
Stochasticity is a quality ubiquitous across Biology. Through it, identical interventions can 
generate different outcomes, even in genetically identical individuals [36]. Recent statistical 
meta-analyses have highlighted the importance of the variance in outcomes, not just their 
mean average. For instance, a low carbohydrate (LC) dietary weight-loss intervention can 
outperform caloric restriction (CR) on average, but in so doing incurs a larger spread of 
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outcomes [37]; a greater proportion of individuals gained weight on LC diet than CR, despite 
LC’s lower average. Rather than determining LC the superior intervention, we must 
understand the mechanisms at play, and stratify patients onto interventions optimal for 
them as individuals. Similar trends exist for the effects of dietary interventions on lifespan, 
arguably an even more critical outcome [38], and the number of food sources on 
evolutionary fitness [39]. The spread of data is important, and stochastic models can offer 
insight into the mechanisms generating it. This requires calibration against the spread, not 
just the mean. The Kolmogorov-Smirnov (KS) statistic represents a powerful tool for 
accomplishing this, Figure 1. This non-parametric statistic is sensitive to differences 
anywhere across two distributions, not only their averages. As illustration, Read et al. 
employed the KS statistic to align in silico with in vivo distributions of leukocyte motility 
characteristics [40]. Only by explicitly modelling and tuning cellular heterogeneity could 
population-level dynamics be reproduced; some cells are inherently faster and more 
directional than others. 
 
We advocate for effect size measures rather than statistical significance (p values) in 
stochastic model calibration [41]. Unless the distributions being contrasted arise from the 
exact same process, statistical significance is always attainable given sufficient replicates, 
Figure 1C. As abstract representations from which additional replicates are trivially 
obtained, models will never be statistically indistinguishable from the biology. Rather than 
aspire to perfect (unattainable) model alignment with biology, we suggest expressing an 
acceptable tolerance in terms of effect size, which is relatively invariant to increasing 
replicates, Figure 1C. Example effect size statistics include: the KS statistic, described in the 
Figure 1 caption; the Vargha-Delaney “A” statistic, which quantifies the probability that a 
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randomly selected sample from one distribution is larger than a randomly selected sample 
from the other, and for which guidelines equating A scores to “small”, “medium” or “large” 
effects exist [42]; and Cohen’s “δ” statistic, the difference between two distributions’ means 
divided by their pooled standard deviation.  
 
Robust stochastic model calibration requires that any observed disparities can be attributed 
to inappropriate model parameter values or mechanisms, rather than artefacts arising from 
an insufficient sample size [15]. However, calibration can entail exploring numerous points 
in parameter space, and acquiring large sample sizes (model executions) for each point can 
compound into considerable computational expense, particularly for agent-based models. 
Modellers may wish to select a statistical precision (sample size) in accordance with the 
computational capacity available. A technique to quantify how many replicates are needed 
to reduce the contribution of stochasticity to a desired level was derived in [15], and 
implemented in [43]. It entailed contrasting n (e.g. 20) groups of model execution replicates, 
all generated under identical parameter values, using the Vargha-Delaney “A” statistic. This 
procedure was repeated with varying numbers of replicates, after which the maximum “A” 
statistic score obtained amongst group comparisons was plotted against sample size used. 
The authors sought the minimum sample size delivering a maximum “A” statistic score 
indicating a “small” effect [15]. This technique essentially performs “mock” parameter 
adjustments, therein quantifying the portion of an observed difference in model output 
(when calibrating proper) attributable to model stochasticity for the sample size used. There 
is no value in attempting to calibrate beyond this baseline level of alignment: any 
improvements would likely represent sampling artefacts rather than an improved model. 
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The “A” statistic was used because it formed the basis of subsequent analyses; any other 
statistic more relevant to the given calibration effort can be substituted.   
 
 
Single metrics alone may not fully distinguish complex systems 
 
Most conventional model fitting techniques require a single metric to quantify the 
difference between modelled and biological dynamics. However, complex biological systems 
are not necessarily quantifiable through single metrics alone. They constitute numerous 
types of interacting component with many-to-many mappings between components and 
functions, and encompass both positive and negative feedback loops [44,45]. A single metric 
may not be fully distinguishing in such a system. This can render a system, and a putative 
model thereof, non-identifiable [20]: multiple distinct component configurations and 
dynamics can produce the same value. For instance, motility research has classically 
employed “mean squared displacement” to quantify how far agents travel on average over 
time [46]. Typically used to characterise search behaviour on a scale of “localised” to 
“highly-directional”, this metric is nonetheless non-distinguishing. Slow-moving directional 
agents can yield the same mean squared displacement as fast-moving non-directional 
agents, and yet the spatial coverage, and hence interactions, of these agents can differ 
vastly [47,48]. 
 
In lieu of a more distinguishing metric, the only recourse is to instead employ a suite of 
them [49]. Yet, this is not readily applicable to standard model fitting techniques given their 
reliance on single metrics. Multi-objective optimisation (MOO) technologies can offer a 
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solution [50]. The differences between target biological and model dynamics, as measured 
by each metric, are posed as separate objectives to be minimised through MOO, Figure 2A 
[14,51]. MOO typically employs a guided search to find solutions, in this case parameter 
values, that best satisfy the objectives. Given its abstractive nature, no single set of 
parameter values will likely provide a perfect model alignment across all metrics. Rather, 
tradeoffs will exist, where given parameter values will provide better alignment on some 
metrics than others, Figure 2B. MOO provides a Pareto front of optimal parameter value 
sets: those for which performance improvement in any one metric necessitates worsening 
in another. Knowledge of these tradeoffs can inform modellers’ adoption of parameter 
values from calibration [14,49]. 
Alternatively, subsequent experiments can be replicated using all Pareto front parameter 
values, thereby exposing the extent to which results hinge on calibration choices rather than 
the intervention [51]. 
 
MOO-based calibration has found extensive application outside of Biology, in the calibration 
of hydrological models [52]; water basin properties are not sufficiently constrained by single 
metrics alone [49]. Elsewhere, Newland et al. calibrate land-use models through MOO, 
employing objectives quantifying capture of absolute location and patterns in land use [14]. 
In a Biological context, we demonstrated MOO-based calibration for models of murine 
multiple sclerosis [51] and leukocyte search behaviour [40]. The former employed metrics 
capturing the proliferation dynamics of several leukocyte populations involved in disease 
onset and subsequent recovery, recapitulating a prior expert-informed manual calibration 
effort [24]. The latter overcame the aforementioned mean squared displacement 
drawbacks by using a complementary suite of motility metrics. 
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Imperative in model fitting is the detection of overfitting, wherein the model captures not 
only general biological behaviours but also the specific noise nuances of the (training) 
dataset against which it is fitted. The standard approach of detecting overfitting through a 
separate, independent validation dataset not used for training can be ported to the multi-
objective context [51]. Separate Pareto fronts are maintained with respect to both datasets, 
and overfitting is indicated through the proportion of training dataset Pareto front member 
solutions that are not also members of the validation dataset Pareto front, Figure 2C.  
 
MOO-based calibration approach can facilitate model selection by contrasting the Pareto 
fronts generated under competing putative models [40,51], Figure 2D. The superior model’s 
Pareto front will contain solutions offering better tradeoffs than alternatives. However, 
there currently exists no formal framework to control for model complexity under this 
approach, such as in the Akaike information criteria. Hence, the technique may simply select 
the most complex model. This can be mitigated by formulating the number of model 
parameters, or some other measure of model complexity, as an objective to be minimised 
[53]. The tradeoff of better biological capture versus model complexity is thus made explicit, 
allowing modellers to select accordingly. 
 
The “NSGA-II” algorithm is a very popular MOO implementation [54]. However, the more 
recent Universal-NSGA-III improves scalability to many objectives, which can otherwise lead 
to a cumbersomely large number of similar solutions [55], Figure 2E. We provide an open-
source implementation of Universal-NSGA-III at 
https://github.com/marknormanread/unsga3. The NSGA algorithms generate putative 
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solutions through a genetic algorithm, employing natural selection and genetic 
recombination processes to iteratively improve quality. There exist other solution-
generation strategies compatible with the Pareto front concept, as reviewed in [56].  
 
 
Calibrating against multiple scenarios 
 
In curve fitting and regression, one attempts to fit (well-understood) equations to data, 
predicting how a dependent variable varies with one or more independent 
variables/predictors. Curve-fitting canon prescribes two data points to fit a line, three for a 
curve, and more if the data is noisy. The fitted equation permits extrapolation between and 
beyond known data points, and reasoning over how predictors drive system response. 
Herein exist clear parallels to modelling biological systems. With the model we aim to 
predict the biological system’s behaviour (dependent variable) under a given context, and 
gain mechanistic understanding. “Context” here encompasses the abstract space of possible 
experiments, conditions or environments to which a biological system can be subjected, 
which equates to predictors. For simplicity we refer to points in this space as scenarios. This 
analogy highlights the prudence of “fitting” the model against multiple scenarios, Figure 3. 
Otherwise, how can we be confident that the model will yield accurate predictions when 
used in predicting biological behaviour beyond what is already known? Any equation, and 
arguably, incorrect model, can be fitted to a single data point. Incorrect models can be 
identified as such through the heavy modifications to mechanics and parameter values they 
require to reproduce behaviour under each scenario. Such modifications compensate for 
the model’s inadequate biological capture. 
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Yet, rarely does modelling literature report model calibration procedures, let alone against 
multiple scenarios. Model fitting against single scenarios and demonstrating the ability to 
reproduce an independent experiment’s outcomes, not used in calibration, is sometimes 
reported [58,59]. This is akin to the training-test/validation splits commonly used in 
machine learning to detect over-fitting of statistical models, and we consider it good 
practice. For instance, following calibration, Palumbo et al. validated their model of energy 
homeostasis in relation to physical exercise against six independent real-world datasets, 
encompassing 69 demographically diverse study participants [60]. One might argue that 
fewer calibration data points are required in biological modelling, owing to a-priori 
biological knowledge informing model design. We counter this position: one cannot 
guarantee that a model is appropriate, and calibration is a valuable independent test 
thereof. 
 
Though not reported in the context of model calibration, Bloch and Harel verified that their  
model of tumour growth matched several known biological cases [61]. These include 
tumour growth being contingent on angiogenesis, non-cancerous cell viability in the 
absence of angiogenesis, and tumour angiogenesis being impeded if blood vessels were too 
distant. Kamal et al. calibrated their model of influenza and antiviral recombination therapy 
in two stages: firstly against placebo patient data, after which additional parameters were 
estimated by fitting against drug-receiving patient data [62]. Gullo et al. also report a multi-
stage calibration for their model of in vitro hematopoietic stem cell expansion under a given 
cytokine milieu [34]. Their work is particularly notable for the sheer number of experimental 
scenarios, representing combinations of cytokine exposures, informing their calibration: 20 
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combinations, each performed in vitro, in triplicate. Successfully calibrating against such a 
comprehensive exploration of possible cytokine exposures instils considerable confidence 
that their subsequent in silico experiments are trustworthy. In developing a computational 
model of the murine autoimmune disease Experimental Autoimmune Encephalomyelitis, we 
simultaneously calibrated against two experimental scenarios [24]: physiological recovery of 
mice post-induction of disease, and a hindered recovery following targeted ablation of a 
given T cell population. We evaluated each putative parameter value set against both 
scenarios simultaneously, seeking values that provided alignment in both experiments. Our 
calibration effort was manual, guided by a domain expert [15]. In hindsight, we believe a 
more thorough, and certainly less time-consuming, calibration could have been 
accomplished through application of MOO, with each metric used in each scenario 
comprising an objective. Herein, a single set of parameter values that accurately reproduces 
target behaviours with a given model can be considered a successful calibration. 
Alternatively, one could use conventional single-metric calibration techniques for each 
scenario independently, seeking a single set of parameter values providing good alignment 
across all calibration exercises. 
 
 
Calibrating with measures of emergent properties 
 
Quantifying a model in the same terms as the real biological system can facilitate adoption 
and interpretation of modelling results [63]. The development of powerful 3D model 
visualisation engines attests to this [64]. A model that is “seen” to look like the real system 
can help biologists appreciate what the model shows, and raise confidence that it is 
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representative of the biology [2,65]. It has been argued that similar quantifications of the 
real biology can be applied to models and used in their calibration [63]. Yet the metrics 
through which biological systems are quantified range from direct assays of individual 
systems components to observations of whole-system state (emergent properties). For 
instance, cell counting through flow cytometry is a fairly direct measure of system 
components. Likewise for histology and imaging, though in all three cases expression 
measurements can be biased by differing marker affinities for their targets [66]. At the other 
extreme lies metrics such at those used in disease model quantification. In the murine 
autoimmune disease Experimental Autoimmune Encephalomyelitis (EAE), disease severity is 
scored on a scale of 0 to 5, capturing the progression of paralysis from tail through hind-, 
then fore-, legs, ultimately culminating in death [67]. The K/BxN arthritis mouse model 
scores the severity in each paw from 0-3 and takes the sum thereof [68]. 
 
The degree to which such metrics can enable calibration depends on how directly they 
relate to a model’s components, and here these metrics occupy a spectrum. Exemplifying 
one extreme, Butler et al. developed a tool-chain facilitating flow cytometry, protein 
expression heatmap and histology analyses for a model of pre-natal lymphoid organ 
development [63]. These metrics were directly tied to processes explicit in the spatial agent-
based model. Further along the spectrum, calibration of Cilfone et al. and Warsinske et al.s’ 
granuloma models necessitated their development of a transformation from 2D modelled 
microbial load to 3D real-world equivalents [69,70]. Finally, at the other extreme lies Read 
et al.’s EAE model disease severity scoring metric [24]. EAE paralysis emerges from the 
effects of molecular-level interference with neurons that spans the entire central nervous 
system. This level of detail and spatial scale, from the molecular to the whole-organism, far 
 19 
exceeded the model’s scope. Instead, modelled EAE severity scoring was based on the 
exposure of neurons to pro-inflammatory cytokines, which they believed would serve as a 
proxy. The result was a complicated fitting exercise requiring data smoothing, Fourier 
transforms, and, importantly, a calibrated model deemed representative of two real-world 
experiments where rates and degrees of fluctuations in mouse paralysis were known [71]. 
 
All these metrics proved useful for interpreting modelling results. However, the degree to 
which they can be used in calibration depends on how directly they pertain to directly 
observable modelled components. Metrics are less readily applicable in model calibration if 
they themselves require calibration, particularly if this necessitates an a priori calibrated 
model. 
 
 
Sensitivity and uncertainty analyses aid calibration and guide interpretation 
 
Complex models comprising many parameters can prove challenging to calibrate. For 
instance, if real-world data against which to calibrate is scarce with respect to model 
complexity, the problem may be non-identifiable: more data is needed to constrain all the 
model’s free variables. Sensitivity analysis (SA) can help target the calibration effort at the 
most influential subset of model parameters [13,16,72]. Less influential parameters are 
“fixed,” assigning values measured in the real system or extracted from the literature where 
possible. 
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SA describes a suite of analyses that quantify how variation of a model's output (response) 
relates to variation of its inputs (samples of model parameter space) [73,74], Figure 4A. In 
global SA, all (or many) parameters are perturbed simultaneously. Alternative one at a time 
SA approaches vary single parameters whilst holding others to some default value; these are 
best applied when those default values are well-motivated, often only after calibration has 
been performed. Global SA can quantify which parameters are most influential on model 
behaviour, and is sensitive to compound effects where one parameter's influence is 
dependent on values held by others. SA consists of a strategy to systematically vary 
parameter values coupled with a way of quantifying these with changes in output. A simple 
strategy to vary inputs is a factorial design, Figure 4B, in which a set of values is selected for 
individual each parameter, and their cartesian product then forms combinations of 
parameter values to explore: all possible combinations are utilised. This sampling strategy is 
robust to sampling artefacts, and its comprehensive exploration of parameter space yields 
highly representative results. However, it also incurs considerable computational expense 
when applied to all but the most computationally efficient models. Latin hypercube design 
offers a more efficient, yet still thorough, exploration of parameter space [75], Figure 4C. 
Representative model behaviour, termed the response, is obtained for each sample of 
parameter space and is then related to each individual parameter, Figure 4D. The partial 
rank correlation coefficient (PRCC) is particularly suitable here, it is sensitive to non-linear 
trends whilst minimising the effect of confounding co-variates (e.g. correlations between 
parameters) [76]. It is critical that samples are selected to minimise any correlation between 
parameters, as these sampling artefacts confound subsequent analysis, Figure 4E. More 
influential parameters will have larger PRCCs with the response. Many other SA techniques 
exist, and are extensively reviewed in [74]. The Latin hypercube-PRCC method is 
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implemented in [43]. Confidence that calibration has delivered an appropriate model is 
raised if the parameters and associated mechanisms SA highlights as influential are 
congruent with what is known of the biology. 
 
From a modelling perspective, lack of precise knowledge concerning some aspect of the 
biology is termed epistemic uncertainty [77]. This can concern, for instance, rates, 
probabilities, population sizes, or any figures pertaining to model parameters. 
Knowledge, or otherwise, of plausible ranges for parameter values derived from the biology 
can help contextualise the scientific significance of in silico experimentation. This can be 
done in two ways. First, whilst calibration can assign appropriate parameter values, those 
values resembling what is well-established biologically will raise trust in the model. This is 
most relevant for highly influential parameters. Conversely, if the model is highly sensitive 
to parameters about which very little is known biologically, caution when interpreting 
results is advisable. Second, one might moderate the interpreted scientific significance of an 
intervention if the resultant changes in model behaviour lie well within the range of 
behaviours possible under epistemic uncertainty. This can be gauged through an uncertainty 
analysis [74,78], which quantifies the diversity of model behaviours possible within the 
ranges of parameter values that current biological knowledge supports. Such an analysis can 
be performed in a one at a time fashion. Alternatively, building a factorial design or Latin 
hypercube around biologically-supported ranges of parameter values equates to a global 
UA, Figure 5A & B. An in silico intervention can be considered scientifically significant if it 
yields behavioural changes far exceeding that explainable under biological uncertainty,  
Figure 5C. For ease of illustration this discussion assumes discrete boundaries of 
“biologically plausible values.” However, in many cases biologically uncertainty may be 
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better expressed in terms of probability distributions, and probabilistic uncertainty analyses 
do exist [79].  
 
 
Conclusion 
 
As the old adage goes, “all models are wrong but some are useful” [80]. No model will ever 
perfectly reflect a complex biological system under all circumstances. Given sufficient effort, 
calibration will always reveal inconsistencies between model and reality. The importance of 
a model accurately reflecting a biological system under given scenarios is problem-specific. 
We would demand greater fidelity of a model directing clinical practice than one employed 
in notional, preliminary exploration [81]. The cost of capturing finer biological nuance is 
model complexity, which poses conceptual and calibration challenges; consider another 
adage, “everything should be made as simple as possible, but not simpler.” Accordingly, 
modellers should document their calibration activities and the justifications therefor. This 
can take the form of evidencing in MIRIAM [82], or comprising part of a structured 
argument that the model is fit for its designated purpose [83]. 
 
Rigorous calibration can instil confidence that a model appropriately captures a biological 
system, or, if unsuccessful, motivate further model development. The strategies we have 
explored here aim to increase the rigour of calibration. In curve fitting, the further away one 
extrapolates from known data points, the less accurate predictions will be. The same 
principle applies to biological models, and the scenarios their calibration covered (Figure 3). 
Being conceptual, this space of scenarios has no objective notion of distance. However, 
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selecting calibration scenarios that exercise the full dynamic range of model components 
and their possible interactions should maximise the range of scenarios under which the 
model proves accurate. 
 
The ultimate validation for a model is arguably that an in silico prediction be experimentally 
verified. For instance, Pappalardo et al.’s prediction that beta sitosterol, a citrus-derived 
compound, would serve as a powerful adjuvant for influenza A virosome vaccindation a was 
subsequently verified experimentally in mice [84]. A goal of calibration is to supply evidence 
and confidence of a model’s quality, which can help make the case for investment in such 
end-stage experimental validations.  
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Key Points: 
¥! The value of biological models hinges on either knowing they are accurate 
representations of the biology, or establishing otherwise; this is ascertained through 
calibration. 
¥! Stochastic models calibrated against the distribution of biological outcomes can help 
ascertain how these diverging outcomes arise from system components and they 
dynamics.  
¥! Even where all model parameter values are experimentally ascertained, calibration is 
still warranted to account for the simplifications and abstractions that models make.  
¥! Single metrics alone may be non-distinguishing for complex systems, resulting in 
multiple solutions to the calibration problem. Multi-metric calibration can overcome 
this and make explicit trade-offs in accurate biological capture across metrics. 
¥! Model calibration is ideally performed against multiple experimental conditions or 
contexts. To do otherwise is akin to curve fitting against a single data point.  
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Figures and Captions: 
 
 
 
Figure 1: The Kolgmogorov-Smirnov (KS) “D” statistic permits model calibration against distributions 
of biological outcomes. Such calibration requires sensitive detection of discrepancies between two 
distributions: that of the target biological behaviour and that of the model. (A) An evaluation of the 
sensitivity of two commonly used statistics, the Mann Whitney U (also called the Wilcoxon rank-sum 
test) and the T test, and the KS statistic. All three fail to determine statistically significant differences 
(p-values) between statistically identical Gaussian distributions, as would be expected, and all three 
are sensitive to changes in distribution mean values. However, only the KS test is sensitive to 
changes in variance in distributions with identical mean values. We advocate for calibrating 
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stochastic models with the KS “D” value, which quantifies the largest difference between the 
proportions of two distributions occurring at or below a given value. This is intuitively visualised (B) 
as the vertical arrow on a cumulative distribution plot. (C) The KS “D” is an effect size measure, and 
is thus relatively insensitive to the number of samples in the distributions being contrasted. 
Conversely, statistical significance (p values) quantify the probability that the given difference 
between two distributions could occur through random chance. Given two non-identical 
distributions, statistical significance is always obtainable with a sufficient sample size. Non-
significant p-values are shown in light grey. We provide methodological details for this figure in the 
supplementary materials. 
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Figure 2: Model calibration and selection using multi-objective optimisation (MOO). (A) The 
divergence between modelled and real biological system behaviours must be quantified. MOO-
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calibration can accommodate multiple such quantifications using different measures of system 
behaviour (only one shown). The example shows how distributions of modelled and real-world 
behaviour can be aligned using the Kolmogorov-Smirnov (KS) statistic. Cumulative distribution plots 
are related to histograms, they show the proportion of data in a distribution less than or equal to a 
given value. Other forms of quantification, such as mean squared error or alternative statistics, may 
be substituted if more appropriate. (B) Each quantification of the difference between modelled and 
real-world behaviour comprises an objective for MOO to minimise by exploring model parameter 
values. It is highly unlikely that that any single set of parameter values perfectly satisfies all 
objectives; rather, tradeoffs in performance are typical. A Pareto front comprises the subset of 
solutions for which an improvement in any one objective necessitates a worsening in another; the 
remaining solutions are sub-optimal. For clarity, only two objectives and model parameters are 
depicted; many more of both are possible. (C) Imperative in model fitting is the detection of 
overfitting, wherein models capture not only general trends but the specific noise nuances of the 
training dataset, therein reducing the generality of the model. Overfitting is typically detected 
through an independent validation dataset not used in model training. Model capture of general 
biological properties will lead to closer alignment with both training and validation datasets. 
Conversely, when overfitting occurs model alignment with the training dataset will continue to 
improve, but alignment with the validation dataset will worsen. This overfitting detection strategy 
can be ported to the multi-objective context by maintaining Pareto fronts with respect to both 
training and validation datasets. Training dataset Pareto front member solutions that are not also 
members of the validation dataset Pareto front are indicative of overfitting, and calibration should 
be terminated when a predetermined portion of the training dataset Pareto front satisfies this 
criteria. (D) The Pareto front concept can facilitate model selection. The superior model will better 
align with real world behaviours, manifesting as smaller tradeoffs in objective scores. This model’s 
Pareto front will dominate those of inferior alternatives. If modellers have reason to preference 
particular metrics/objectives, they can focus on sub-regions of the models’ Pareto fronts. (E) The 
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number of solutions comprising the Pareto front typically grows exponentially with the number of 
objectives used; “Universal Non-dominated Sorting Genetic Algorithm” (U-NSGA-III) constrains the 
Pareto front whilst encouraging a diversity of solutions. This is accomplished by preferentially 
retaining Pareto front solutions closest to an evenly distributed set of reference vectors in objective 
space. These vectors intersect each of the evenly distributed points on a unit hyperplane and it’s 
origin. The hyperplane is normalised using the maximum and minimum objective scores across the 
Pareto front. For more information on MOO and its use in calibration, see references [40,51,55,57]. 
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Figure 3: Fitting models against biological behaviour under multiple experiments, conditions or 
environments (e.g. x1, x2) affords greater confidence that the model will accurately predict 
biological system performance (r(x)) in scenarios for which this is not known (grey box, x3). Almost 
any model can be fitted against a single data point. However, unrepresentative models (m1(x)) will 
fail to reproduce system behaviour across multiple scenarios without heavy alterations to parameter 
values or mechanics to account for their inadequacy. Employing multiple experiments or scenarios in 
calibration can highlight inadequate models. 
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Figure 4: (A) Sensitivity analysis quantifies how variation of a model's output relates to variation of 
its inputs (parameters). It commences with a systematic sampling of model parameter space. (B) 
Given a set of values to explore for each parameter, factorial design samples every possible 
combination thereof. Obtaining representative model behaviours for each sample, particularly for 
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stochastic models where repeat executions are required, can incur considerable computation 
expense under factorial design. (C) Latin hypercube design represents a more efficient sampling of 
space, whilst still encouraging an extensive coverage. The range of values of interest for each 
parameter are segregated into intervals, and each is sampled once. Note that intervals need not be 
evenly spaced, and can instead concentrate samples around areas of particular interest.  
(D) Parameter influences on the response can be quantified through the partial rank correlation 
coefficient, which is sensitive to non-linear effects. (E) It is essential to minimise correlations 
between parameters when sampling (e.g. Latin hypercube design), these artefacts confound the 
partitioning of observed effects between parameters that are correlated. In this example, three 
distinct possibilities are non-distinguishable because parameters 1 and 2 are sampled in a correlated 
manner: both parameters are equally influential on model output, parameter 1 is influential and 
parameter 2 has no effect, or vice versa. This figure depicts only two model parameters for clarity. 
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Figure 5: Contextualising in silico experimental scientific significance by contrasting effect size 
against range of model behaviours possible given biological uncertainty (epistemic uncertainty). (A) 
Sample model parameter space within region of biologically plausible parameter values. Shown is a 
Latin hypercube, but other sampling schemes can be substituted. Gather representative model 
behaviours within this region, and (B) quantify range of model behaviours explainable given current 
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epistemic uncertainty. (C) Interventions resulting in model behaviour changes lying within the range 
explained by epistemic uncertainty have relatively little scientific significance. Conversely, 
interventions delivering effects far exceeding this range may be highly significant. 
 
